Virtual Medicinal Product (VMP) - Papaverine 30mg/2ml solution for injection ampoules
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Papaverine 30mg/2ml solution for injection ampoules | Start Date 08-02-2012 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 2.0
- UDFS UOM
- ml
- Unit Dose UOM
- ampoule
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intracavernous
- Form
- Solution for injection
- Ontology Form/Route
- solutioninjection.intracavernous
- Name Basis
- BAN - British Approved Name
Codes
- ATC Code
- G04BE02
- BNF Codes
-
- BNF code 07040500
Code | Start Date | End Date |
---|---|---|
20003111000001102 | 08-02-2012 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Papaverine hydrochloride | Based on Ingredient Substance | 15 mg | 1 ml |
Name
Papaverine hydrochloride
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
15.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMPapaverine
-
VMP(Current) Papaverine 30mg/2ml solution for inj...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
1 ampoule | ||
10 ampoule |